3
2
1

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

2026/07/22

The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

2026/04/24

Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

2026/03/04

The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

2026/02/02

On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).

World’s First Achievement Highlights Brand Leadership

2026/01/19

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

2026/01/04

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.

2022-08-22

Yinfeng Biotech joins hands with Changyu to advocate a healthy life

On the morning of August 22, Jiang Hua, deputy general manager of Changyu Group and general manager of brandy business department, and his party came to Yinfeng Biotechnology Park for a visit and exchange. Sheng Dewei, Vice President of Yinfeng Group and Chairman of Yinfeng Biological Group, Liu Xu, Vice President of Yinfeng Group and Chairman of Property Group, Wang Baoqing, President of Yinfeng Biological Group, Bai Xinjing, General Manager of Shandong Deren Economic and Trade Co., Ltd., and Han Zhen, General Manager of Shandong Qilu Cell Therapy Engineering Technology Co., Ltd., attended the event.On the morning of August 22, Jiang Hua, deputy general manager of Changyu Group and general manager of brandy business department, and his party came to Yinfeng Biotechnology Park for a visit and exchange. Sheng Dewei, Vice President of Yinfeng Group and Chairman of Yinfeng Biological Group, Liu Xu, Vice President of Yinfeng Group and Chairman of Property Group, Wang Baoqing, President of Yinfeng Biological Group, Bai Xinjing, General Manager of Shandong Deren Economic and Trade Co., Ltd., and Han Zhen, General Manager of Shandong Qilu Cell Therapy Engineering Technology Co., Ltd., attended the event.On the morning of August 22, Jiang Hua, deputy general manager of Changyu Group and general manager of brandy business department, and his party came to Yinfeng Biotechnology Park for a visit and exchange. Sheng Dewei, Vice President of Yinfeng Group and Chairman of Yinfeng Biological Group, Liu Xu, Vice President of Yinfeng Group and Chairman of Property Group, Wang Baoqing, President of Yinfeng Biological Group, Bai Xinjing, General Manager of Shandong Deren Economic and Trade Co., Ltd., and Han Zhen, General Manager of Shandong Qilu Cell Therapy Engineering Technology Co., Ltd., attended the event.On the morning of August 22, Jiang Hua, deputy general manager of Changyu Group and general manager of brandy business department, and his party came to Yinfeng Biotechnology Park for a visit and exchange. Sheng Dewei, Vice President of Yinfeng Group and Chairman of Yinfeng Biological Group, Liu Xu, Vice President of Yinfeng Group and Chairman of Property Group, Wang Baoqing, President of Yinfeng Biological Group, Bai Xinjing, General Manager of Shandong Deren Economic and Trade Co., Ltd., and Han Zhen, General Manager of Shandong Qilu Cell Therapy Engineering Technology Co., Ltd., attended the event.On the morning of August 22, Jiang Hua, deputy general manager of Changyu Group and general manager of brandy business department, and his party came to Yinfeng Biotechnology Park for a visit and exchange. Sheng Dewei, Vice President of Yinfeng Group and Chairman of Yinfeng Biological Group, Liu Xu, Vice President of Yinfeng Group and Chairman of Property Group, Wang Baoqing, President of Yinfeng Biological Group, Bai Xinjing, General Manager of Shandong Deren Economic and Trade Co., Ltd., and Han Zhen, General Manager of Shandong Qilu Cell Therapy Engineering Technology Co., Ltd., attended the event.On the morning of August 22, Jiang Hua, deputy general manager of Changyu Group and general manager of brandy business department, and his party came to Yinfeng Biotechnology Park for a visit and exchange. Sheng Dewei, Vice President of Yinfeng Group and Chairman of Yinfeng Biological Group, Liu Xu, Vice President of Yinfeng Group and Chairman of Property Group, Wang Baoqing, President of Yinfeng Biological Group, Bai Xinjing, General Manager of Shandong Deren Economic and Trade Co., Ltd., and Han Zhen, General Manager of Shandong Qilu Cell Therapy Engineering Technology Co., Ltd., attended the event.On the morning of August 22, Jiang Hua, deputy general manager of Changyu Group and general manager of brandy business department, and his party came to Yinfeng Biotechnology Park for a visit and exchange. Sheng Dewei, Vice President of Yinfeng Group and Chairman of Yinfeng Biological Group, Liu Xu, Vice President of Yinfeng Group and Chairman of Property Group, Wang Baoqing, President of Yinfeng Biological Group, Bai Xinjing, General Manager of Shandong Deren Economic and Trade Co., Ltd., and Han Zhen, General Manager of Shandong Qilu Cell Therapy Engineering Technology Co., Ltd., attended the event.On the morning of August 22, Jiang Hua, deputy general manager of Changyu Group and general manager of brandy business department, and his party came to Yinfeng Biotechnology Park for a visit and exchange. Sheng Dewei, Vice President of Yinfeng Group and Chairman of Yinfeng Biological Group, Liu Xu, Vice President of Yinfeng Group and Chairman of Property Group, Wang Baoqing, President of Yinfeng Biological Group, Bai Xinjing, General Manager of Shandong Deren Economic and Trade Co., Ltd., and Han Zhen, General Manager of Shandong Qilu Cell Therapy Engineering Technology Co., Ltd., attended the event.

2022-08-12

The Peking University Alumni Association visited Yinfeng Biological Group

On August 12th, a visiting delegation composed of Peking University Alumni Association, Peking University Youth CEO Club, and Peking University School of Innovation and Entrepreneurship visited Yinfeng Biological Group for inspection.

2022-08-10

Strengthening the Deep Integration of Industry

From August 9th to 10th, Zhang Guirong, Assistant to the President and R&D Director of Yinfeng Biotechnology Group, and Liu Zhicheng, Head of Yinfeng Cryotherapy, were invited to visit and exchange ideas at the University of Science and Technology of China and Shanghai Institute of Technology. They also discussed the development of low-temperature biomedical technology with the Executive Director of the International Cryotherapy Society, Professor Zhao Gang from the University of Science and Technology of China, a member of the International Cryotherapy Biomedical Society, and Professor Xu Yi from Shanghai Institute of Technology, Full exchanges were held on the joint development and cooperation of high-end technologies, as well as the establishment of expert committees.

2022-08-01

Yinfeng Low Temperature Medicine: -196 ℃, Exploring the Chinese Temperature of Life Sciences

In the extraordinary decade, Chinese companies have emerged with countless warm brand stories, which we call "Chinese Temperature". Starting from August 2022, the Advertising Research Center of Shandong University, the Shandong Provincial Brand Building Promotion Association, and the Qilu Evening News One Point Think Tank jointly plan the "China Temperature" public welfare communication action, aiming to showcase the "China Temperature" of Shandong enterprises from multiple perspectives, accumulate brand strength, forge ahead on a new journey, and contribute to the new era.

2022-07-26

Xiao International Education and Research Camp Enters Shandong Yinfeng Life Science Research Institute

Shandong Yinfeng Life Science Research Institute will continue to uphold the mission and responsibility of "dedicating medical technology and ensuring human health", and continue to play the role of "Life Science Education Popularization Base" to support the progress of life science and low-temperature medicine!

2022-03-29

Zhang Haidong and his delegation from Shandong First Medical University (Shandong Academy of Medical Sciences) visited and conducted research at Yinfeng Biotechnology Group

On March 29th, Zhang Haidong, Executive Vice President of the School of Clinical and Basic Medicine at Shandong First Medical University (Shandong Academy of Medical Sciences), Yue Yun, Deputy Secretary of the Party Committee, and Wang Dandan, Vice President, visited and conducted research at Yinfeng Biotechnology Group. Zhang Cheng, President of Yinfeng Biotechnology Group, Zhang Guirong, Assistant to the President and Director of Research and Development Department, and Hu Jinkun, Director of Human Resources Department, accompanied the delegation.

< 1...121314...17 >